This page was created by volunteers like you!
Help us make it even better. To learn more about contributing to MEpedia, click here.
Join the movement
Visit #MEAction to find support or take action. Donate today to help us improve and expand this project.
Congratulations!
MEpedia has got over 30 million views as of August 2022!

Adaptive immune system

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

The adaptive immune system, sometimes called the acquired immune system, learns to destroy pathogens. Its ability to learn (for example from vaccines) in this way distinguishes it from the innate immune system. It works by first identifying "non-self", it then generates a response to the pathogen, and finally it develops a memory of that response to reuse in future.

The main components of the system are:

Rituximab[edit | edit source]

The cancer drug Rituximab targets CD20 receptors on B cells and so targets the adaptive immune system.

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]